Mizoram records the first case of Multisystemic Inflammatory Syndrome in Children (MIS-C)

No Comments
Posted in Featured, Mizoram

Ezrela Daldia Fanai, NET Correspondent, Mizoram

A suspected case of Multisystemic Inflammatory Syndrome in Children (MIS-C) has been detected at a hospital in Mizoram, informed Dr. Pachuau Lalmalsawma, State Nodal Officer and Official Spokesperson on COVID-19. The patient is a six-year-old boy who had returned from Delhi and was admitted to Synod Hospital, Durtlang on June 4 due to diarrhea and fever.

Multisystem inflammatory syndrome in children (MIS-C) is a serious condition that is linked with coronavirus infection. Most children infected with Covid-19 develop only a mild symptom. But those who escalate to MIS-C develop inflammations in the heart, lungs, blood vessels, kidneys, digestive system, brain, skin, or eyes.

Senior Paediatrics Consultant Dr. John Malsawma of Synod Hospital, Durtlang along with two senior doctors- Dr. Pachuau Lalmalsawma and State Epidemiologist Dr. R.Lalrintluanga visited the Synod Hospital, Durtlang on June 12 where the suspected case of MIS-C was reported. They collected all the details of the MIS-C patient and sent them to Emergency Medical Relief (EMR), New Delhi for further analysis.

“We have diagnosed the first case of Multisystemic Inflammatory Syndrome in Children (MIS-C) in Mizoram here in our hospital. Initially, we were not aware that the child was suffer(ing) from MIS-C, but as conventional treatment did not work, and the child has a history of being exposed to Covid-19, we gave him treatment as per the protocol of CDC,” Dr. John Malsawma, Senior Paediatrics Consultant of Durtlang Hospital said.

Dr. John said, “It is a hyper-immune response to Covid-19, and is not contagious. If appropriate treatments are given, it is not life-threatening. But one should take care that there should not be cardiac involvement, as the child can go into hypo-tension shock.”

Leave a Reply

Your email address will not be published.

Fill out this field
Fill out this field
Please enter a valid email address.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

The reCAPTCHA verification period has expired. Please reload the page.

More Articles